Topics

P16, P21 Biomarkers Linked to Treatment Response in Osteosarcoma

13:03 EST 29 Jan 2020 | OncLive

C. Parker Gibbs, MD, discusses the research behind p16 and p21 as predictive biomarkers for treatment response in patients with osteosarcoma.

Original Article: P16, P21 Biomarkers Linked to Treatment Response in Osteosarcoma

NEXT ARTICLE

More From BioPortfolio on "P16, P21 Biomarkers Linked to Treatment Response in Osteosarcoma"

Quick Search